{
    "2018-07-26": [
        [
            {
                "time": "2018-07-25",
                "original_text": "Wall Street Analysts Estimate a Decline in Sanofi’s Adjusted EPS in Q2",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Adjusted EPS",
                        "Decline",
                        "Q2"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Could Sanofi’s Sales Decline Again in Q2 2018?",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Sales",
                        "Decline",
                        "Q2",
                        "2018"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-27",
                "original_text": "Celgene Raises Revenue Guidance after Solid Growth in Q2 2018",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Revenue Guidance",
                        "Solid Growth",
                        "Q2",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-28",
                "original_text": "Glaxo (GSK) Q2 Earnings & Sales Beat Estimates, '18 View Up",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "GSK",
                        "Q2",
                        "Earnings",
                        "Sales",
                        "Beat Estimates",
                        "View Up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-29",
                "original_text": "Gilead (GILD) Q2 Earnings & Sales Beat Eclipsed by CEO Exit",
                "features": {
                    "keywords": [
                        "Gilead",
                        "GILD",
                        "Q2",
                        "Earnings",
                        "Sales",
                        "Beat",
                        "CEO Exit"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-30",
                "original_text": "The Swiss Stock Market Jumped On Broad Strength",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Jumped",
                        "Broad Strength"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "Initiating Free Research Reports on Pfizer and Three Other Drug Makers Equities",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Drug Makers",
                        "Equities",
                        "Research Reports"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "Omeros Announces Voluntary Dismissal Of Infringement Suit Against Sandoz",
                "features": {
                    "keywords": [
                        "Omeros",
                        "Voluntary Dismissal",
                        "Infringement Suit",
                        "Sandoz"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "Biotech Stocks Facing FDA Decision In August",
                "features": {
                    "keywords": [
                        "Biotech Stocks",
                        "FDA Decision",
                        "August"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}